Formation Medecine

Icas 2012 : 2nd International Cell Assisted Surgery Congress



The 28th Congress of the International Council of the Aeronautical Sciences (ICAS 2012) will be held on 23-28 September 2012 at the Brisbane Convention & Exhibition Centre, Brisbane, Australia.

The ICAS Congress is a biennial five-day event which brings together world aeronautics experts and the entire international scientific aerospace community to discuss, understand and compare worldwide scientific and technological advances. The Congress provides the ideal opportunity to move aeronautical research and technology progressively forward, particularly with regards to environment and sustainable development. ICAS 2012 is set to attract more than 600 delegates worldwide, with 40 countries represented.

The Congress will attract:

World aeronautics experts Engineers Researchers PhD students Aviation authorities

Local Organising Committee

Cees Bil Committee Chair – RMIT University Cam Macphee Deputy Committee Chair – Brisbane Airport Corporation Pty Ltd Duncan Campbell Committee Member – Australian Research Centre for Aerospace Automation Reece Clothier Committee Member – Australian Research Centre for Aerospace Automation Christopher Hess Committee Member – Department of Employment, Economic Development and Innovation, Queensland Government Ian Honnery Sponsorship & Exhibitions; Public Relations & Media – Aerospace Maritime and Defence Foundation of Australia Limited Glenn Luke Committee Member – Australian Aerospace Limited Catriona McAullife Finance & Contracts - Engineers Australia Nandini Rego Committee Member – Aerospace Maritime and Defence Foundation of Australia Limited Murray Scott ICAS Liaison & Program – Advanced Composite Structures Australia Pty Ltd & ICAS Executive Brad Wheatley Committee Member – BK Education


Cancer : quand la guérison se lit dans la flore intestinale

La présence de certaines bactéries dans les intestins de patients atteints d?un mélanome augure du succès de la thérapie.

ESC Congress 2012

The European Society of Cardiology presents the world's premier conference on the science, management and prevention of cardiovascular disease.

2012 spotlight: "From bench to practice"
Translating innovative science into daily clinical practice is a challenge shared by clinical scientists and clinical physicians. Only through concerted efforts can we continue to bring further improvements to patient care. By choosing translational science as its 2012 congress spotlight the ESC will encourage critical discussion of new techniques and their rapid transfer into clinical medicine.

9 Main Topics:
. Arrhythmias
. Heart Failure/LV Dysfunction
. Valvular Disease/Pulmonary Circulation
. Myocardial-Pericardial Disease
. Congenital Heart Disease & Paediatric Cardiology
. Ischaemia/CAD/ACC
. Interventions/Peripheral Circulation/Stroke/Surgery
. Prevention/Rehabilitation/Sports/Nursing
. Hypertension/Pharma
. Basic Science
. Cardiac Imaging/Computers

Submission deadlines:
. Mid-December 2011- 14 February 2012: Abstract submission
. 1 May 2012: Hot Lines, Clinical Trial Updates and Clinical Registry Highlights submission
. 15 May 2012 : Science Hot Line submission

Tel: +33 (0)4 92 94 76 00 - Fax: +33 (0)4 92 94 76 01

Facts & Figures from ESC Congress 2011:
. 32 897 attendees
. 12 163 m² exhibition space
. 200 exhibitors
. 208 guest faculty
. 521 sessions
. 143 topics
. Over 10 000 abstracts submitted
. 4 276 abstracts selected
. 39 Hotlines, Clinical Trial Updates
. 12 Focus Sessions
. 144 countries

Join us in Munich!


Comment grossit-on ?

VIDÉO - Quel est le mécanisme lorsqu?on grossit ? Par malchance, notre corps adore stocker les graisses mais déteste s?en délester. Explications avec le Pr Lecerf, chef du service nutrition à l?Institut Pasteur de Lille.

ICAO 2012, 3rd International Congress on Abdominal Obesity

The 3rd International Congress on Abdominal Obesity (ICAO 2012) is a highly anticipated event that will build on the success of last year's Congress, held in Buenos Aires, Argentina. The Congress's primary objective is to bring together medical professionals from all specialties to exchange ideas and information about and raise awareness of abdominal obesity as a new modifiable risk factor which, along with traditional risk factors, plays a central role in this new concept of global cardiometabolic risk.

This relatively new Congress's innovative multidisciplinary approach has facilitated the development of a new medical paradigm, whereby complications as hypertension, dyslipidemia, type 2 diabetes, and cardiovascular disease are no longer evaluated and treated in isolation.

Des armées de chercheurs pilonnent le paludisme

Les spécialistes estiment que même si l?on obtenait un vaccin efficace à seulement 80 %, l?éradication du paludisme pourrait être envisagée.

The World Congress of Clinical Lipidology

 This is the first conference of this kind and aimed at health care professionals, who would like to increase their knowledge in lipid disorders.
Lipid disorders remain amongst the most important treatable risk factors for cardiovascular diseases. While we have better and better drugs available to treat dyslipidemias, residual risk remains and many patients do not reach their targets.
This conference aims to deal with all aspects of lipid disorders from diagnosis to treatment, from diet to novel lipid lowering drugs, from adverse events to compliance issues.
Current and future lipid lowering therapies will be discussed in plenary lectures and small workshops by world leaders in lipidology
Leading clinicians from around the world will contribute to a cutting edge program that aims to capture the scope and depth of the exciting field of lipidology.

Pour bien mincir, il faut sortir du diktat des régimes

VIDÉO - Pour sa grande première, la nouvelle émission santé du Figaro Live aborde la question des régimes avec le médecin nutritionniste Jean-Michel Lecerf. Vous pouvez revoir l?émission en replay.

Atelier 215 : Diversité des transcriptomes non codants révélés par RNA-seq

Contexte et Objectifs

Le développement des techniques de séquençages à haut-débit a conduit à l’explosion des connaissances dans le domaine de la génomique et de la transcriptomique. En particulier, les années récentes ont révélé l'extrême diversité qualitative et quantitative des ARNs non codants nucléaires et cytoplasmiques qui comprennent de très courts (TSS-RNAs, miRNA…) comme de très longs transcrits (lncRNAs). Les concepts de spécificité et de fonction de ces nouveaux transcrits ainsi que du bruit transcriptionnel peuvent désormais être ré-envisagé sous un jour nouveau. L'atelier proposé abordera les aspects conceptuels et pratiques des ARNs non codant dans les organismes procaryotes, eucaryotes uni- et multicellulaire, tout en abordant des questions ayant trait au développement et à la différentiation dans un contexte normal ou pathologique.


Plusieurs aspects du transcriptome non codant seront traités :

- Transcription pervasive

- ARN non codant associés aux promoters et enhancers

- ARNs non codant régulateurs

- Approches alternatives pour l’identification (méthode bioinformatique, nouvelles approches de séquencage)


Piero Carninci (Riken Inst, Kanagawa, Japan), Philippe Couttet (Novartis, Bale, Switzerland), Daniel Gautheret (Univ Paris-Sud, Paris, France), Alain Jacquier (Inst. Pasteur, Paris, France), Torben Jensen (Aahrus Univ, Aahrus, Denmark), John Lis (Cornell Univ, USA), John Mattick (IMB Queensland, Brisbane, Australia), Patrice Milos (Helicos, Cambridge, USA), Gioacchino Natoli (Campus IFOM-IEO, Milan, Italy), Ramesh Pillai (EMBL, Grenoble, France), Christopher Ponting (Oxford Univ, Oxford, UK), Jorg Vogel (Molecular Infection Inst, Wurzburg, Germany)

Comité d'organisation

Inserm - Ateliers de formation 


Comité scientifique

Jean-Christophe Andrau (CIML, Marseille, France), Antonin Morillon (Institut Curie, Paris, France)

Date limite d'inscription : 26 mars 2012


Implant Essure : pour le comité d?experts, inutile de changer la règlementation

Pour les huit experts réunis par l?Agence du médicament chargés d?en évaluer les risques, la balance bénéfice/risques de l?implant de stérilisation est favorable.

Formation Hopital

Ez Implants

Congres Medecine Sport

Congres Genetique

Congres Medical 1